SCHEMBL7695589

SCHEMBL7695589

COc1ccc(SCc2nc3cc4ccccc4cc3nc2CSc2ccc(OC)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.46
ALDH1A1 P00352 7/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
KDM4E B2RXH2 4/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
LMNA P02545 2/20 0.45
NQO2 P16083 2/20 0.45
POLB P06746 1/20 0.45
DAO P14920 1/20 0.43
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
MAPT P10636 3/20 0.42
HTT P42858 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
NFKB1 P19838 3/20 0.42
NFKB2 Q00653 3/20 0.42
RELA Q04206 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694096 0.84 NPC1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7698454 0.83 NQO2 (0.45) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7697719 0.81 NPC1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7697768 0.77 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7689877 0.75 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL7695424 0.75 CYP1A2 (0.42) NPC1RAB9AKMT2AMEN1LMNA
SCHEMBL2433694 0.73 APP (0.69) APPALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7697161 0.72 MAOA (0.43) RAB9ANQO2MAOBMAOAMAPT
SCHEMBL7697050 0.72 TDP1 (0.44) ALDH1A1KMT2AMEN1LMNANQO2
SCHEMBL3228582 0.70 APP (0.82) APPALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed